ARONEX PHARMACEUTICALS, INC.
Exhibit 11.1
The following reflects the information used in calculating the number of shares
in the computation of net loss per share for each of the periods set forth in
the Statements of Operations.
Average
Days Shares Shares Loss Per
Shares Outstanding X Days Outstanding Loss Share
Six Months Ended June 30, 1996:
10,380,056 1 10,380,056
10,390,003 10 103,900,030
10,409,608 4 41,638,432
10,418,676 2 20,837,352
10,478,786 1 10,478,786
10,046,458 3 30,139,374
10,598,792 1 10,598,792
10,678,561 2 21,357,122
10,680,653 1 10,680,653
10,680,903 3 32,042,709
10,710,132 4 42,840,528
10,718,504 6 64,311,024
10,727,170 4 42,908,680
10,728,565 1 10,728,565
10,729,263 1 10,729,263
10,729,394 7 75,105,758
10,731,487 19 203,898,253
10,742,559 7 75,197,913
10,771,115 2 21,542,230
10,775,477 2 21,550,954
10,776,991 4 43,107,964
10,784,842 1 10,784,842
10,812,921 1 10,812,921
10,832,546 2 21,665,092
10,847,725 3 32,543,175
10,848,023 5 54,240,115
10,849,767 7 75,948,369
10,851,626 3 32,554,878
10,858,605 1 10,858,605
10,862,095 2 21,724,190
10,962,004 1 10,962,004
10,962,593 4 43,850,372
10,965,241 2 21,930,482
10,965,939 1 10,965,939
10,967,993 6 65,807,958
10,972,354 5 54,861,770
10,977,356 2 21,954,712
10,978,310 7 76,848,170
10,983,980 4 43,935,920
10,989,215 1 10,989,215
13,992,587 1 13,992,587
13,996,077 1 13,996,077
13,996,949 6 83,981,694
14,446,949 1 14,446,949
14,453,492 5 72,267,460
14,456,109 5 72,280,545
14,465,806 1 14,465,806
14,472,786 2 28,945,572
14,473,658 1 14,473,658
14,478,658 3 43,435,974
14,481,500 1 14,481,500
14,483,680 3 43,451,040
14,484,059 1 14,484,059
14,485,899 2 28,971,798
14,488,079 3 43,464,237
14,526,802 3 43,580,406
182 2,097,932,529/182 11,527,102 (4,400,000) (0.38)
ARONEX PHARMACEUTICALS, INC.
Exhibit 11.1
The following reflects the information used in calculating the number of shares
in the computation of net loss per share for each of the periods set forth in
the Statements of Operations.
Average
Days Shares Shares Loss Per
Shares Outstanding X Days Outstanding Loss Share
Six Months Ended June 30, 1997:
14,597,247 8 116,777,976
14,606,972 12 175,283,664
14,612,023 4 58,448,092
14,612,499 21 306,862,479
14,615,983 6 87,695,898
14,616,981 1 14,616,981
14,624,239 5 73,121,195
14,625,111 2 29,250,222
14,627,695 7 102,393,865
14,628,567 6 87,771,402
14,640,311 6 87,841,866
14,643,658 6 87,861,948
14,644,672 1 14,644,672
14,644,816 7 102,513,712
14,644,982 2 29,289,964
14,645,277 4 58,581,108
14,665,277 22 322,636,094
14,665,665 9 131,990,985
14,674,453 19 278,814,607
14,678,042 6 88,068,252
14,680,055 7 102,760,385
14,680,344 19 278,926,536
14,687,394 1 14,687,394
181 2,650,839,297/181 14,645,521 (6,294,000) (0.43)
ARONEX PHARMACEUTICALS, INC.
Exhibit 11.1
The following reflects the information used in calculating the number of shares
in the computation of net loss per share for each of the periods set forth in
the Statements of Operations.
Average
Days Shares Shares Loss Per
Shares Outstanding X Days Outstanding Loss Share
Quarter Ended June 30, 1996:
10,847,725 5 54,238,625
10,848,023 7 75,936,161
10,849,767 3 32,549,301
10,851,626 1 10,851,626
10,858,605 2 21,717,210
10,862,095 1 10,862,095
10,962,004 4 43,848,016
10,962,593 2 21,925,186
10,965,241 1 10,965,241
10,965,939 6 65,795,634
10,967,993 5 54,839,965
10,972,354 2 21,944,708
10,977,356 7 76,841,492
10,978,310 4 43,913,240
10,983,980 1 10,983,980
10,989,215 1 10,989,215
13,992,587 1 13,992,587
13,996,077 6 83,976,462
13,996,949 1 13,996,949
14,446,949 5 72,234,745
14,453,492 5 72,267,460
14,456,109 1 14,456,109
14,456,806 2 28,913,612
14,472,786 1 14,472,786
14,473,658 3 43,420,974
14,478,658 1 14,478,658
14,481,500 3 43,444,500
14,483,680 1 14,483,680
14,484,059 2 28,968,118
14,485,899 3 43,457,697
14,488,079 3 43,464,237
14,526,802 1 14,526,802
91 1,128,757,071 /91 12,404,122 (2,327,000) (0.19)
Quarter Ended June 30, 1997: 0
14,644,816 2 29,289,632
14,644,982 2 29,289,964
14,645,277 4 58,581,108
14,665,277 22 322,636,094
14,665,665 9 131,990,985
14,674,453 19 278,814,607
14,678,042 6 88,068,252
14,680,055 7 102,760,385
14,680,344 19 278,926,536
14,687,394 1 14,687,394
91 1,335,044,957 /91 14,670,824 (3,201,000) (0.22)